FOXO4-DRI Dosage Calculator & Research Doses

1Set Up Your Mix

20 mg/mL · 20000 mcg/mL

1. Pick your peptide

2. How much peptide is in the vial? It's printed on the label — usually something like 5 mg

3. How much water are you adding? More water makes each dose easier to measure

4. How much do you want per dose?

All answers assume a standard 1 mL U-100 syringe, where 1 unit = 0.01 mL. That is the usual insulin syringe and the one every number here is based on.

Your Answer — FOXO4-DRIYour Answer

—

25Draw To This Line

0.25That's This Many mL

2Doses In The Vial

10 mg ÷ 0.5 mL = 20 mg/mL → 5 mg ÷ 20 mg/mL = 0.25 mL → × 100 = 25 units—

Looks good. Draw to 25 units on a 1 mL syringe. That is an easy amount to measure, and this vial gives you 2 doses.

2Week-By-Week Plan — FOXO4-DRI

not applicable

When	Dose	How Often	How Many mL	Draw To	Number Of Doses	Peptide Used
Research study dose	5 mg/kg weight-based	3× per cycle, alternate days	Set by body weight — can't be turned into a single amount to draw
Community reported	5 mg	every other day ×3	0.25 mL	25 u	2 doses

No week-by-week plan for FOXO4-DRI. This one is dosed by body weight, comes ready-mixed, or only has a single dose reported — so there is nothing to work up through.

3Common Doses — FOXO4-DRI

worked out for your mix

Level	Dose	How Often	How Many mL	Draw To	Doses In Vial

Please read this. These numbers come from published research. They are here as reference, not as instructions. A lot of them come from lab studies rather than studies in people, and some of these peptides have never been given to a person at all.

About FOXO4-DRIAbout This Peptide

Longevity & Bioregulator

Also known as

FOXO4-D-Retro-Inverso peptide

Class

Longevity & Bioregulator

Route

Subcutaneous

Half-life

Short

Evidence tier

Preclinical

A senolytic peptide that disrupts the FOXO4–p53 interaction, selectively triggering apoptosis in senescent cells. The research data are striking; there is no human dosing data whatsoever, and the mechanism is intrinsically cytotoxic.

Buy FOXO4-DRIthis peptide

Opens optimal-pep.com in a new tab

Where These Numbers Come From

Preclinical — Preclinical and in-vitro data only — no human dosing trials

Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging Baar MP, et al. Cell, 2017

The originating senolytic study; the sole substantive reference for this compound.

Find on PubMed ↗

Newest Studies — —

—

Not reviewed by us. This list is pulled straight from Europe PMC as papers are published. Nobody has checked whether these are any good, or whether they change anything above. The dose numbers on this page only ever change after a person reviews the evidence.

More peptides

Browse the full catalogue, or jump to a neighbouring compound.

Research Use Only — Confirm to Continue

FOXO4-DRI Dosage & Reconstitution